共 50 条
- [1] RISK FACTOR ANALYSIS OF ALLOGENEIC HEMAPOIETIC CELL TRANSPLANTATION (HCT) FOR FOLLICULAR LYMPHOMA (FL). A RETROSPECTIVE STUDY ON BEHALF OF THE EBMT (THE EUROPEAN GROUP FOR BLOOD AND MARROW TRANSPLANTATION) LYMPHOMA WORKING PARTY AND THE CIBMTR (CENTER FOR INTERNATIONAL BLOOD AND MARROW TRANSPLANT RESEARCH) LYMPHOMA WORKING COMMITTEE. [J]. ANNALS OF ONCOLOGY, 2011, 22 : 94 - 94
- [2] Allogeneic Transplantation for Relapsed/Refractory (R/R) Follicular Lymphoma (Fl). A Joint Study Between the European Society for Blood and Marrow Transplantation (EBMT) and the Center for International Blood and Marrow Transplant Research (CIBMTR) [J]. BONE MARROW TRANSPLANTATION, 2016, 51 : S68 - S68
- [6] Autologous (auto) versus matched sibling donor (MSD) or matched unrelated donor (MUD) allogeneic (allo) hematopoietic cell transplantation (HCT) in follicular lymphoma (FL) patients (pts) with early chemoimmunotherapy failure (ECF): A Center for International Blood and Marrow Transplant Research (CIBMTR) analysis. [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35